Prenetics Global Limited filed a Form 6-K on November 2, 2026, disclosing the resignation of Chief Financial Officer Stephen Hoi Chun Lo and the planned appointment of Brian Rosin as principal financial and accounting officer.

Key Highlights

  • Resignation date: Stephen Hoi Chun Lo tendered his resignation as Chief Financial Officer on October 30, 2026, effective December 30, 2026.
  • Reason stated: According to the filing, Mr. Lo is departing "to pursue new opportunities."
  • Continued service: Mr. Lo will remain Chief Financial Officer through December 30, 2026, and will then support the company in an advisory capacity.
  • Successor named: Brian Rosin is set to become principal financial and accounting officer effective December 31, 2026, subject to board approval and execution of a formal agreement.
  • Current role of successor: Mr. Rosin currently serves as Chief Financial Officer of IM8 (US) LLC, described in the filing as the company's main operating subsidiary.
  • Tenure noted: The filing states the company is grateful to Mr. Lo for "his dedication and valuable contributions over the past eight years."

Prenetics Discloses CFO Transition Effective December 2026

Prenetics Global Limited (NASDAQ:PRE), a foreign private issuer headquartered in Hong Kong, filed a Form 6-K for the month of November 2026, reporting a leadership change in its finance function. According to the filing, Stephen Hoi Chun Lo submitted his resignation as Chief Financial Officer on October 30, 2026, with an effective date of December 30, 2026. The company disclosed that Mr. Lo is leaving to pursue new opportunities after eight years of service.

The filing states that Mr. Lo will continue in his current role through his resignation date and will then transition to an advisory role with the company. Prenetics disclosed that Brian Rosin has been identified as his successor, with an appointment as principal financial and accounting officer planned for December 31, 2026. The filing notes that the appointment remains subject to approval by the company's board of directors and the execution of a formal agreement.

According to the filing, Mr. Rosin currently performs principal financial and accounting functions for IM8 (US) LLC, identified as the company's main operating subsidiary, where he holds the title of Chief Financial Officer. The Form 6-K was signed by Danny Sheng Wu Yeung, Chief Executive Officer, on November 2, 2026, and is incorporated by reference into several of the company's registration statements on Form F-3 and Form S-8 filed with the SEC.

What Was Disclosed

Prenetics Global Limited reported the resignation of CFO Stephen Hoi Chun Lo, effective December 30, 2026, and the planned appointment of Brian Rosin as principal financial and accounting officer effective December 31, 2026, subject to board approval.